These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 9457812

  • 1. Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade glioma.
    Rajkumar SV, Buckner JC, Schomberg PJ, Cascino TL, Burch PA, Dinapoli RP.
    Int J Radiat Oncol Biol Phys; 1998 Jan 15; 40(2):297-302. PubMed ID: 9457812
    [Abstract] [Full Text] [Related]

  • 2. Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
    Rajkumar SV, Buckner JC, Schomberg PJ, Pitot HC, Ingle JN, Cascino TL.
    Neurosurgery; 1999 Jan 15; 44(1):67-73. PubMed ID: 9894965
    [Abstract] [Full Text] [Related]

  • 3. A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma.
    Buckner JC, Schomberg PJ, McGinnis WL, Cascino TL, Scheithauer BW, O'Fallon JR, Morton RF, Kuross SA, Mailliard JA, Hatfield AK, Cole JT, Steen PD, Bernath AM.
    Cancer; 2001 Jul 15; 92(2):420-33. PubMed ID: 11466698
    [Abstract] [Full Text] [Related]

  • 4. Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma.
    Rajkumar SV, Buckner JC, Schomberg PJ, Reid JM, Bagniewski PJ, Ames MM, Cascino TL, Marks RS.
    Int J Radiat Oncol Biol Phys; 1998 Dec 01; 42(5):969-75. PubMed ID: 9869217
    [Abstract] [Full Text] [Related]

  • 5. Phase II trial with BCNU plus alpha-interferon in patients with recurrent high-grade gliomas.
    Brandes AA, Scelzi E, Zampieri P, Rigon A, Rotilio A, Amista P, Berti F, Fiorentino MV.
    Am J Clin Oncol; 1997 Aug 01; 20(4):364-7. PubMed ID: 9256890
    [Abstract] [Full Text] [Related]

  • 6. Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy.
    Raizer JJ, Malkin MG, Kleber M, Abrey LE.
    Neuro Oncol; 2004 Jul 01; 6(3):247-52. PubMed ID: 15279717
    [Abstract] [Full Text] [Related]

  • 7. Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma.
    Buckner JC, Brown LD, Kugler JW, Cascino TL, Krook JE, Mailliard JA, Kardinal CG, Tschetter LK, O'Fallon JR, Scheithauer BW.
    J Neurosurg; 1995 Mar 01; 82(3):430-5. PubMed ID: 7861221
    [Abstract] [Full Text] [Related]

  • 8. Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors.
    Prados MD, Larson DA, Lamborn K, McDermott MW, Sneed PK, Wara WM, Chang SM, Mack EE, Krouwer HG, Chandler KL, Warnick RE, Davis RL, Rabbitt JE, Malec M, Levin VA, Gutin PH, Phillips TL, Wilson CB.
    Int J Radiat Oncol Biol Phys; 1998 Jan 01; 40(1):57-63. PubMed ID: 9422558
    [Abstract] [Full Text] [Related]

  • 9. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a].
    Kirchner HH, Atzpodien J, Poliwoda H.
    Med Klin (Munich); 1996 Apr 12; 91 Suppl 3():44-9. PubMed ID: 8692119
    [Abstract] [Full Text] [Related]

  • 10. Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma.
    Dinapoli RP, Brown LD, Arusell RM, Earle JD, O'Fallon JR, Buckner JC, Scheithauer BW, Krook JE, Tschetter LK, Maier JA.
    J Clin Oncol; 1993 Jul 12; 11(7):1316-21. PubMed ID: 8315428
    [Abstract] [Full Text] [Related]

  • 11. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.
    Jeremic B, Grujicic D, Antunovic V, Djuric L, Stojanovic M, Shibamoto Y.
    Int J Radiat Oncol Biol Phys; 1994 Dec 01; 30(5):1179-85. PubMed ID: 7961028
    [Abstract] [Full Text] [Related]

  • 12. The effects of sequential versus concurrent chemotherapy and radiotherapy on survival and toxicity in patients with newly diagnosed high-grade astrocytoma.
    Kleinberg L, Grossman SA, Piantadosi S, Zeltzman M, Wharam M.
    Int J Radiat Oncol Biol Phys; 1999 Jun 01; 44(3):535-43. PubMed ID: 10348282
    [Abstract] [Full Text] [Related]

  • 13. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.
    Chang CH, Horton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S, Weinstein A, Nelson JS, Tsukada Y.
    Cancer; 1983 Sep 15; 52(6):997-1007. PubMed ID: 6349785
    [Abstract] [Full Text] [Related]

  • 14. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.
    Vokes EE, Haraf DJ, Drinkard LC, Hoffman PC, Ferguson MK, Vogelzang NJ, Watson S, Lane NJ, Golomb HM.
    Cancer Chemother Pharmacol; 1995 Sep 15; 35(4):304-12. PubMed ID: 7530173
    [Abstract] [Full Text] [Related]

  • 15. Treatment of recurrent malignant glioma with BCNU-fluosol and oxygen inhalation. A phase I-II study.
    Hochberg F, Prados M, Russell C, Weissman D, Evans R, Cook P, Burton G, Eisenberg PD, Valenzuela R, Verkh L.
    J Neurooncol; 1997 Mar 15; 32(1):45-55. PubMed ID: 9049862
    [Abstract] [Full Text] [Related]

  • 16. Early chemotherapy and concurrent radio-chemotherapy in high grade glioma.
    Brandes AA, Rigon A, Zampieri P, Scelzi E, Amistà P, Berti F, Rotilio A, Gardiman M, Fiorentino MV.
    J Neurooncol; 1996 Dec 15; 30(3):247-55. PubMed ID: 8943100
    [Abstract] [Full Text] [Related]

  • 17. Safety of thrice-daily hyperfractionated radiation and BCNU for high-grade gliomas.
    Rao RD, Thomé SD, O'Fallon J, Earle JD, Dinapoli RP, Buckner JC.
    Int J Radiat Oncol Biol Phys; 2002 Jun 01; 53(2):376-84. PubMed ID: 12023142
    [Abstract] [Full Text] [Related]

  • 18. Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: a cytokine working group study.
    Dutcher JP, Logan T, Gordon M, Sosman J, Weiss G, Margolin K, Plasse T, Mier J, Lotze M, Clark J, Atkins M.
    Clin Cancer Res; 2000 Sep 01; 6(9):3442-50. PubMed ID: 10999727
    [Abstract] [Full Text] [Related]

  • 19. A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma.
    Mittelman A, Huberman M, Puccio C, Fallon B, Tessitore J, Savona S, Eyre R, Gafney E, Wick M, Skelos A.
    Cancer; 1990 Aug 15; 66(4):664-9. PubMed ID: 2386896
    [Abstract] [Full Text] [Related]

  • 20. Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas.
    Fine HA, Wen PY, Maher EA, Viscosi E, Batchelor T, Lakhani N, Figg WD, Purow BW, Borkowf CB.
    J Clin Oncol; 2003 Jun 15; 21(12):2299-304. PubMed ID: 12805330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.